Huber Capital Management LLC Boosts Stock Position in Tenet Healthcare Corporation $THC

Key Points

• Huber Capital increased its stake in Tenet Healthcare (NYSE:THC) by 21.3% in Q3 to 51,301 shares (about $10.4M), representing roughly 1.6% of Huber's portfolio and the firm's 22nd-largest holding.
• Significant insider selling occurred on March 2, when EVP Thomas W. Arnst sold 24,000 shares and R. Scott Ramsey sold 8,017 shares; insiders have sold 42,195 shares (~$9.82M) over the past quarter and now hold 0.81% of the stock.
• Analysts are growing more bullish—consensus is a Moderate Buy with a $250.56 target—after Tenet beat quarterly EPS estimates ($4.70 vs. $4.08) and set FY2026 guidance of $16.19–$18.47 EPS.

Huber Capital Management LLC grew its stake in Tenet Healthcare Corporation (NYSE:THC - Free Report) by 21.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 51,301 shares of the company's stock after purchasing an additional 9,000 shares during the period. Tenet Healthcare makes up approximately 1.6% of Huber Capital Management LLC's portfolio, making the stock its 22nd biggest holding. Huber Capital Management LLC owned about 0.06% of Tenet Healthcare worth $10,416,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. BNP Paribas Financial Markets increased its position in Tenet Healthcare by 4.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 183,124 shares of the company's stock worth $37,181,000 after purchasing an additional 8,588 shares during the period. FourThought Financial Partners LLC purchased a new position in shares of Tenet Healthcare in the third quarter valued at $320,000. Vestcor Inc boosted its position in shares of Tenet Healthcare by 132.4% in the 3rd quarter. Vestcor Inc now owns 13,986 shares of the company's stock worth $2,840,000 after buying an additional 7,969 shares in the last quarter. WINTON GROUP Ltd purchased a new position in Tenet Healthcare during the 3rd quarter valued at about $7,748,000. Finally, Schroder Investment Management Group lifted its holdings in shares of Tenet Healthcare by 165.8% in the third quarter. Schroder Investment Management Group now owns 40,497 shares of the company's stock valued at $8,148,000 after purchasing an additional 25,262 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Tenet Healthcare

In related news, EVP Thomas W. Arnst sold 24,000 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president owned 8,012 shares of the company's stock, valued at $1,875,128.48. The trade was a 74.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The SEC filing for this sale provides additional information. Insiders have sold 42,195 shares of company stock worth $9,823,406 over the last quarter. 0.81% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

THC has been the subject of several analyst reports. Leerink Partners upped their target price on Tenet Healthcare from $255.00 to $264.00 and gave the stock an "outperform" rating in a research report on Friday, February 20th. Truist Financial upped their target price on Tenet Healthcare from $240.00 to $270.00 and gave the company a "buy" rating in a research report on Tuesday, February 17th. Royal Bank Of Canada upped their price target on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an "outperform" rating in a report on Thursday, February 12th. TD Cowen reissued a "buy" rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Weiss Ratings raised Tenet Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $250.56.

Tenet Healthcare Stock Performance

Shares of NYSE THC traded down $0.67 during mid-day trading on Friday, hitting $224.06. The company had a trading volume of 46,456 shares, compared to its average volume of 1,013,159. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The firm's 50 day simple moving average is $212.89 and its two-hundred day simple moving average is $203.65. The stock has a market cap of $19.48 billion, a price-to-earnings ratio of 14.47, a PEG ratio of 1.15 and a beta of 1.39. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $247.21.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the business earned $3.44 earnings per share. Tenet Healthcare's revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.